Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Schizophr Res. 2009 Aug 22;115(2-3):317–324. doi: 10.1016/j.schres.2009.07.019

Figure 2. Mean nicotine plasma levels across the 2-hour ad-lib smoking period no nicotine deprivation [A] and nicotine deprivation [B] by diagnosis (schizophrenic smokers vs. control smokers) and medication (mecamylamine vs. placebo).

Figure 2